Pfeifer1982.
You have an effective writing style which is very persuasive. There is no reason whatsoever for you not to quote one clinical trial against another.... so long as you provide some balance. Cell harvesting techniques have moved on dramatically since 2013 and the numbers and potency levels you have referred to for MSB production processes are completely out of date. So if you want to come on the Mesoblast website and crow about how CYN's latest clinical trial results compare to our clinical test done in 2013....I want to provide some balance to the discussion so other readers understand why I believe your calculations and assumptions are irrelevant ! Good luck waiting for those Phase 2 results...come back in a few years time and we can have a proper discussion.
In the meantime, CYN is very fortunate to potentially have a major company in Fuji to champion their clinical programmes..hopefully they act honourably and you will be rewarded for your investment. Your posts on the other thread are very well informed... I will be closely watching to make sure you don't make too much money without me
GVHD in US, page-28
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |